Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma-Reference-Cited by-同舟云学术

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

Published:2017-11-28 Issue:3 Volume:180 Page:365-373
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Flinn Ian W.¹^ORCID,Thompson Dana S.¹,Boccia Ralph V.²,Miletello Gerald³,Lipman Andrew⁴,Flora Douglas⁵,Cuevas Daniel⁶,Papish Steven W.⁷,Berdeja Jesus G.¹

Affiliation:

1. Sarah Cannon Research Institute/Tennessee Oncology PLLC; Nashville TN USA

2. Center for Cancer and Blood Disorders; Bethesda MD USA

3. Hematology/Oncology Clinic; LLP; Baton Rouge LA USA

4. Florida Cancer Specialists; Ft. Myers FL USA

5. Oncology Hematology Care, Inc.; Cincinnati OH USA

6. St. Louis Cancer Care; LLP; Bridgeton MO USA

7. Hematology-Oncology Associates of Northern NJ; Morristown NJ USA

Funder

Takeda Pharmaceuticals U.S.A.

Teva Pharmaceutical Industries

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15044/fullpdf

Reference25 articles.

1. High rates of long lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's lymphomas;Bremer;Journal of Cancer Research and Clinical Oncology,2002

2. The functional assessment of cancer therapy (FACT) scale: development and validation of the general measure;Cella;Journal of Clinical Oncology,1993

3. Revised response criteria for Malignant Lymphoma;Cheson;Journal of Clinical Oncology,2007

4. Prediction of creatinine clearance from serum creatinine;Cockcroft;Nephron,1976

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

2. Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis;Blood Cancer Journal;2023-09-07

3. A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study);British Journal of Haematology;2021-05-10

4. Systemic Amyloidosis due to Low-Grade Lymphoma;Hematology/Oncology Clinics of North America;2020-12

5. Apoptosis and Cancer;Cancer Immunology;2020